Sanford delivered record FY26 earnings and cut net debt by 43%, but the result was powered by an unusually strong squid catch and a sharp fall in mussel profitability. The NZX-listed seafood group is now betting its strengthened balance sheet can support growth in mussels without surrendering its cost discipline.
- Record NPAT of NZ$74.5 million, up 17%
- Adjusted EBIT rose 11% to NZ$116.6 million
- Net debt fell NZ$39.8 million to NZ$53.6 million
- Wildcatch profit contribution jumped 38% on a strong squid catch
- Mussel profit contribution fell 70% as prices and yields weakened
Record earnings meet a less predictable cash result
Sanford Limited (NZX:SAN) has posted its second consecutive record annual profit, with net profit after tax rising 17% to NZ$74.5 million despite revenue increasing only 2.5% to NZ$598.6 million. Adjusted EBIT reached a record NZ$116.6 million, while earnings per share rose to 79.7 cents from 68.1 cents.
The balance sheet also looks materially different from two years ago. Net debt fell NZ$39.8 million to NZ$53.6 million, finance costs dropped 36% to NZ$7.8 million, and the group finished the year with NZ$46.4 million in cash. That progress was achieved alongside NZ$26.3 million of capital expenditure and a total FY26 dividend of 10 cents per share, including a final fully imputed dividend of 5 cents.
Cash conversion was less impressive than the profit headline. Operating cash flow fell to NZ$89.6 million from NZ$135.3 million, with Sanford attributing the decline to working-capital timing, higher tax payments and a non-cash movement in biological assets. The company describes the result as its second-highest operating cash flow in recent history, but the year-on-year fall is a useful reminder that reported earnings and cash generation did not move in lockstep.
Wildcatch carried the improvement
Wildcatch was the clearest operational winner. Revenue rose 14.2% to NZ$364.1 million and profit contribution increased 38% to NZ$72.3 million. A strong squid catch was the standout factor, while prices were generally firm across the portfolio, apart from scampi. Average sales prices rose 17% even as catch volume fell 9%, reflecting quota and Annual Catch Entitlement constraints.
The result extends the earnings recovery signalled in Sanford’s record interim profit, although the company itself cautions that squid catches are inherently variable. Hoki prices also benefited from shortages in northern hemisphere white fish markets, while the inshore business continued to provide a stable contribution through ACE sales. That combination is favourable, but it is not the same as having unlimited volume growth available.
Salmon earned more from less volume
Salmon profit contribution rose 25% to NZ$62.8 million even as revenue fell 17% to NZ$105.6 million. Sanford prioritised higher-return export markets and achieved a 20.9% increase in average sales price, offsetting a 30.4% fall in harvest volume. The volume reduction was mainly linked to difficulty meeting the minimum size profile required by export markets.
That shift left significantly more biomass in the water at year end, and the increase in the fair value of biological assets was a key contributor to earnings. Feed costs also rose, driven largely by higher fishmeal and fish oil prices. The accounting uplift is part of the audited result, but it means the salmon outcome will need to be judged alongside future harvest volumes, market prices and the eventual conversion of biomass into sales.
Mussels remain the strategic wager
Mussels supplied the year’s sharpest contrast. Revenue fell 9.4% to NZ$113.7 million, while profit contribution plunged 70.4% to NZ$10.3 million. Frozen half-shell prices weakened throughout the year, demand softened in key export markets, and adverse climatic conditions reduced crop condition and processing yields. Sanford also reported a build-up of frozen half-shell inventory, while its Bioactives facility remained below targeted performance levels.
Despite that setback, Sanford is increasing its control of the business. After year end, it acquired the remaining 50% of North Island Mussels Limited from Cedenco Aquaculture, giving it full ownership. The financial terms were not disclosed in the reported material. The company has also begun investing in Western Firth farms and says extended marine-farming consents through to 2044 provide greater certainty for future investment. The strategic logic is clear in the filing: more consented water space and infrastructure could support volume growth with relatively modest capital. The commercial test is whether those assets can earn acceptable returns in a market where Sanford expects further price and demand pressure into FY27.
A stronger platform with a less certain repeat
Management says Sanford is shifting from internal repair to revenue growth, while retaining its commodity-style focus on lower costs, productivity and tighter overhead control. It also warns that several key contributors to FY26 were outside the company’s control and that the result should not be assumed to repeat in FY27. The warning matters: a strong squid season, firm fish prices and a favourable biological-asset movement are not equivalent to recurring structural growth.
The company is carrying less financial risk than it was at the start of its turnaround, but its next test may be operational rather than financial. Mussel pricing, European and US demand, salmon size profiles, feed costs and the economics of full ownership of North Island Mussels will determine whether the balance sheet becomes a platform for compounding earnings or merely a buffer against another uneven seafood season. Separately, Chair Sir Robert McLeod plans to retire at the annual meeting, while Tony Carter will stand for election as an independent director.
Bottom Line?
Sanford has created financial room to invest, but FY27 will show whether mussel expansion can replace the unusually helpful conditions that drove FY26.
Questions in the middle?
- Can full ownership of North Island Mussels lift yields and returns quickly enough to justify further investment while half-shell demand remains weak?
- Will salmon harvest volumes recover as fish reach export specifications, or will higher biomass continue to support earnings without equivalent cash generation?
- How much of FY26’s wildcatch uplift can Sanford repeat if squid catches normalise and hoki prices lose the benefit of northern hemisphere supply shortages?